Table 5.
Frequently reported symptoms by race (n = 2539)
White/Caucasian (n = 2060) | Non-White/Non-Caucasian (n = 479)a | Comparisonb | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All | By COVID-19 test result | All | By COVID-19 test result | |||||||||||
Symptom | Positive | Negative | Odds Ratio | Positive | Negative | Odds Ratio | P-value | P-value | ||||||
% | Nc | % | Nc | % | [95% CI] | % | Nc | % | Nc | % | [95% CI] | Unadjusted | Adjustedd | |
General symptoms | ||||||||||||||
Fatigue/Tiredness | 51.4 | 681 | 58.8 | 377 | 42.4 | 1.96 [1.61–2.38] | 48.0 | 147 | 61.5 | 83 | 36.2 | 3.12 [2.05–4.80] | 0.897 | 0.640 |
Muscle & body aches | 30.3 | 401 | 34.8 | 224 | 25.2 | 1.59 [1.29–1.98] | 35.1 | 112 | 46.5 | 56 | 24.6 | 2.84 [1.83–4.47] | 0.008 | 0.642 |
Joint pains | 30.2 | 406 | 35.3 | 217 | 24.5 | 1.85 [1.49–2.30] | 28.6 | 91 | 37.8 | 46 | 20.2 | 2.99 [1.88–4.85] | 0.910 | 0.756 |
Shortness of breath | 23.2 | 347 | 30.1 | 130 | 14.7 | 2.50 [1.96–3.21] | 22.8 | 81 | 33.9 | 28 | 12.2 | 3.98 [2.40–6.77] | 0.719 | 0.677 |
Cough | 22.0 | 283 | 24.7 | 171 | 19.3 | 1.40 [1.11–1.77] | 24.4 | 74 | 30.8 | 43 | 18.9 | 2.11 [1.32–3.41] | 0.276 | 0.405 |
Brain & nervous system | ||||||||||||||
Headaches | 42.3 | 550 | 49.0 | 321 | 36.7 | 1.49 [1.21–1.82] | 42.8 | 123 | 53.7 | 82 | 37.6 | 1.97 [1.29–3.05] | 0.641 | 0.148 |
Concentration problems | 39.6 | 565 | 49.9 | 250 | 28.5 | 2.49 [2.03–3.07] | 38.2 | 123 | 53.2 | 60 | 27.6 | 3.13 [2.02–4.90] | 0.841 | 0.951 |
Memory problems | 29.4 | 435 | 38.5 | 170 | 19.4 | 2.48 [1.99–3.10] | 30.1 | 99 | 42.9 | 45 | 20.7 | 2.83 [1.80–4.51] | 0.669 | 0.888 |
General weakness | 20.6 | 292 | 25.8 | 132 | 15.1 | 1.96 [1.53–2.52] | 24.0 | 77 | 33.5 | 38 | 17.5 | 2.51 [1.55–4.13] | 0.125 | 0.972 |
Dizziness | 19.4 | 266 | 23.6 | 134 | 15.3 | 1.64 [1.28–2.11] | 20.7 | 66 | 28.7 | 33 | 15.1 | 2.41 [1.44–4.10] | 0.442 | 0.200 |
Balance problems | 18.3 | 250 | 22.2 | 128 | 14.6 | 1.78 [1.38–2.31] | 17.3 | 54 | 23.5 | 29 | 13.5 | 2.46 [1.43–4.34] | 0.980 | 0.709 |
Mental well-being | ||||||||||||||
Difficulty sleeping | 46.1 | 578 | 51.2 | 371 | 42.7 | 1.29 [1.06–1.57] | 44.3 | 127 | 54.7 | 85 | 39.7 | 1.74 [1.15–2.66] | 0.815 | 0.978 |
Anxiety | 46.3 | 568 | 48.8 | 385 | 44.3 | 1.11 [0.90–1.36] | 44.1 | 123 | 53.5 | 88 | 41.3 | 1.43 [0.92–2.21] | 0.638 | 0.086 |
Depression | 33.8 | 423 | 37.5 | 274 | 31.5 | 1.19 [0.96–1.48] | 32.4 | 91 | 39.6 | 64 | 29.6 | 1.28 [0.82–2.01] | 0.949 | 0.840 |
Ears, nose, and throat | ||||||||||||||
Congested nose | 34.3 | 417 | 36.5 | 289 | 32.6 | 1.16 [0.95–1.42] | 31.5 | 94 | 39.7 | 57 | 25.1 | 1.99 [1.29–3.10] | 0.835 | 0.724 |
Ringing in ears | 22.1 | 279 | 24.5 | 177 | 20.1 | 1.33 [1.06–1.68] | 20.0 | 60 | 25.4 | 36 | 15.9 | 1.90 [1.15–3.18] | 0.994 | 0.706 |
Heart or circulation | ||||||||||||||
Irregular heartbeats | 19.3 | 270 | 23.7 | 127 | 14.4 | 1.85 [1.44–2.38] | 19.4 | 68 | 29.1 | 25 | 11.3 | 3.57 [2.10–6.27] | 0.384 | 0.912 |
Leg pain when walking | 16.5 | 232 | 20.4 | 108 | 12.3 | 1.94 [1.48–2.56] | 24.0 | 78 | 33.3 | 37 | 17.0 | 2.40 [1.48–3.95] | <0.001 | 0.026 |
Eyes or vision | ||||||||||||||
Dry eyes | 25.9 | 310 | 27.3 | 224 | 25.5 | 1.25 [1.00–1.56] | 22.8 | 72 | 30.6 | 37 | 16.7 | 2.65 [1.62–4.38] | 0.788 | 0.118 |
Stomach or digestion | ||||||||||||||
Heartburn (reflux) | 23.7 | 308 | 27.2 | 180 | 20.5 | 1.35 [1.08–1.70] | 21.3 | 63 | 27.3 | 39 | 17.5 | 2.13 [1.29–3.59] | 1.000 | 0.821 |
aNon-white/Non-Caucasian categorized as American Indian/Alaskan Native (n = 17), Asian (n = 46), Black/African American (n = 27), Native Hawaiian/Other Pacific Islander (n = 45), Other (n = 344).
bWhite/Caucasian with a positive COVID-19 test result versus Non-White/Non-Caucasian with a positive Covid-19 test result.
cN Reported patient with symptoms.
dAdjusted P-Value for comparing white and non-white COVID-positive patients calculated from Logistic Regression after the adjustment of age, sex, BMI, vaccine status, race/ethnicity, CCI, and time after COVID-19 test.